Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Noriyuki Kawahata is active.

Publication


Featured researches published by Noriyuki Kawahata.


Bioorganic & Medicinal Chemistry Letters | 2003

Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agents.

Chi B. Vu; George P. Luke; Noriyuki Kawahata; William C. Shakespeare; Yihan Wang; Raji Sundaramoorthi; Chester A. Metcalf; Terence P. Keenan; Selvi Pradeepan; Evelyn G. Corpuz; Taylor Merry; Regine S. Bohacek; David C. Dalgarno; Surinder S. Narula; Marie Rose van Schravendijk; Mary K. Ram; Susan Adams; Shuenn Liou; Jeffrey Keats; Shelia M. Violette; Wei Guan; Manfred Weigele; Tomi K. Sawyer

The design of bone-targeted pyrido[2,3-d]pyrimidin-7-ones as Src tyrosine kinase inhibitors is described. Leveraging SAR from known compounds and using structure-based methods, we were able to rapidly incorporate bone binding components, which maintained, and even increased potency against the target enzyme. Compound 4 displayed a high affinity for hydroxyapatite, a major constituent of bone, and demonstrated antiresoprtive activity in our cell-based assay.


Mini-reviews in Medicinal Chemistry | 2002

SRC homology-2 inhibitors: peptidomimetic and nonpeptide.

Tomi K. Sawyer; Regine Bohacek; David C. Dalgarno; Charles J. Eyermann; Noriyuki Kawahata; Chester A. Metcalf; William C. Shakespeare; Raji Sundaramoorthi; Yihan Wang; Michael G. Yang


Archive | 2009

Biologically active peptidomimetic macrocycles

Huw M. Nash; Rosanna Kapeller-Libermann; Tomi K. Sawyer; Noriyuki Kawahata; Vincent Guerlavais; Matthew Iadanza


Archive | 2009

Therapeutic peptidomimetic macrocycles

Huw M. Nash; David Allen Annis; Rosana Kapeller-Libermann; Tomi K. Sawyer; Noriyuki Kawahata; Jiawen Han


Archive | 2009

Peptidomimetic macrocycles with improved properties

Huw M. Nash; David Allen Annis; Rosana Kapeller-Libermann; Tomi K. Sawyer; Noriyuki Kawahata


Biopolymers | 2003

Structure-based design of novel nonpeptide inhibitors of the Src SH2 domain:phosphotyrosine mimetics exploiting multifunctional group replacement chemistry.

Raji Sundaramoorthi; Noriyuki Kawahata; Michael G. Yang; William C. Shakespeare; Chester A. Metcalf; Yihan Wang; Taylor Merry; Charles J. Eyermann; Regine S. Bohacek; Surinder S. Narula; David C. Dalgarno; Tomi K. Sawyer


Bioorganic & Medicinal Chemistry Letters | 2001

A novel phosphotyrosine mimetic 4′-carboxymethyloxy-3′-phosphonophenylalanine (cpp): exploitation in the design of nonpeptide inhibitors of pp60Src SH2 domain

Noriyuki Kawahata; Michael G. Yang; George P. Luke; William C. Shakespeare; Raji Sundaramoorthi; Yihan Wang; Daniel Johnson; Taylor Merry; Shelia M. Violette; Wei Guan; Catherine Bartlett; Jeremy Smith; Marcos Hatada; Xiaode Lu; David C. Dalgarno; Charles J. Eyermann; Regine S. Bohacek; Tomi K. Sawyer


Archive | 2009

Methods for preparing purified polypeptide compositions

Huw M. Nash; Matthew Iadanza; Christopher Leitheiser; Noriyuki Kawahata


Archive | 1998

Novel signal transduction inhibitors, compositions containing them

Manfred Weigele; Regine S. Bohacek; Virginia A. Jacobsen; Karina Macek; Michael G. Yang; Noriyuki Kawahata; Rajeswari Sundaramoorthi; Yihan Wang; Craig Takeuchi; George P. Luke; Chester A. Metcalf; William C. Shakespeare; Tomi K. Sawyer


Archive | 2014

PEPTIDOMIMETIC MACROCYCLES AND USE THEREOF IN REGULATING HIF1ALPHA

Vincent Guerlavais; Noriyuki Kawahata; Huw M. Nash; Carl Elkin; Eric Feyfant

Collaboration


Dive into the Noriyuki Kawahata's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge